Biogen (United States)
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Biogen (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
6.2K
Total Open
Publications
3.3K
Total
Citations
266K
Open Access
Percentage
53%
Total
Publications
6.2K
Total Open
Publications
3.3K
Total
Citations
266K
Breakdown
Publisher Open
18%
Both
25%
Other Platform Open
10%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
748
Hybrid 37%
1K
No Guarantees 35%
947
Other Platform Open
Domain 81%
1.8K
Institution 26%
565
Other Internet 13%
294
Preprint 12%
261
Public 8%
182
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.8K |
Europe PMC | Domain | 1.1K |
DOI | Other Internet | 164 |
Semantic Scholar | Public | 147 |
bioRxiv | Preprint | 130 |
University College London - UCL Discovery | Institution | 113 |
medRxiv | Preprint | 64 |
Figshare | Public | 56 |
Research Square | Preprint | 40 |
California Digital Library - eScholarship | Other Internet | 40 |